The Weekly Dose
Your Weekly Peptide Intelligence
Every Sunday, we distill the week's most important research into a single curated briefing. Five to ten minutes. Zero fluff.
Issue #2·May 10, 2026
New Horizons: Peptides, GLP-1s, and the FDA Big Shift
From FDA rule changes to oral GLP-1 breakthroughs and the most important peptide research of the year, here is what actually matters.
Read issue →Issue #3·May 10, 2026
The Weekly Dose: FDA Peptide Review, Genomic Peptides, and Mitochondrial Signaling
This week's developments in peptide therapeutics: FDA advisory committee meeting, genomic analysis of GHK-Cu, and mitochondrial peptide MOTS-c.
Read issue →Issue #1·April 27, 2026
The Oral GLP-1 Era Begins — And Five Other Things You Need to Know
The first no-strings-attached GLP-1 pill got approved, the FDA is reconsidering 12 peptides, and BPC-157's evidence base just got quantified. Your weekly briefing.
Read issue →